153 related articles for article (PubMed ID: 20551403)
21. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC.
Allibhai Z; Cho BC; Taremi M; Atallah S; Hope A; Hwang D; Keshavjee S; Tsao M; Yasufuku K; Kim SW; Bezjak A
Eur Respir J; 2012 Apr; 39(4):1039-42. PubMed ID: 22467727
[No Abstract] [Full Text] [Related]
22. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
23. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Mason D; Murthy S; Rice TW; Mazzone P; Machuzak M; Mekhail T; Videtic GM
J Thorac Oncol; 2009 Aug; 4(8):976-82. PubMed ID: 19633473
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.
Buyyounouski MK; Balter P; Lewis B; D'Ambrosio DJ; Dilling TJ; Miller RC; Schefter T; Tomé W; Harris EE; Price RA; Konski AA; Wallner PE
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):3-10. PubMed ID: 20643514
[No Abstract] [Full Text] [Related]
25. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure.
Andratschke N; Zimmermann F; Boehm E; Schill S; Schoenknecht C; Thamm R; Molls M; Nieder C; Geinitz H
Radiother Oncol; 2011 Nov; 101(2):245-9. PubMed ID: 21724287
[TBL] [Abstract][Full Text] [Related]
26. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
Videtic GM; Stephans KL; Woody NM; Reddy CA; Zhuang T; Magnelli A; Djemil T
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):203-8. PubMed ID: 25015198
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
28. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
29. [Stereotactic body radiotherapy for malignant nodules in the lung].
Nestle U; Guckenberger M
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S25-31. PubMed ID: 24150852
[TBL] [Abstract][Full Text] [Related]
30. Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
Marwaha G; Stephans KL; Woody NM; Reddy CA; Videtic GM
J Thorac Oncol; 2014 Nov; 9(11):1693-7. PubMed ID: 25185531
[TBL] [Abstract][Full Text] [Related]
31. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
32. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
Pennathur A; Abbas G; Christie N; Landreneau R; Luketich JD
Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
[TBL] [Abstract][Full Text] [Related]
33. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
[TBL] [Abstract][Full Text] [Related]
35. Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?
Senan S; Senthi S
J Thorac Oncol; 2013 Aug; 8(8):995-6. PubMed ID: 23857397
[No Abstract] [Full Text] [Related]
36. A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.
Hiraoka M; Ishikura S
J Thorac Oncol; 2007 Jul; 2(7 Suppl 3):S115-7. PubMed ID: 17603306
[TBL] [Abstract][Full Text] [Related]
37. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
40. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies.
Williams TM; Maier A
Cancer J; 2013; 19(3):272-81. PubMed ID: 23708074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
